Journals / Fırat Tıp Dergisi / 2022 / Cilt: 27 - Sayı: 2

Nitric Oxide Serum Levels in Schizophrenia Subtypes and it’s Relationship with Clinical Variables

Şizofreni Alttiplerinde Serum Nitrik Oksit Düzeyleri ve Klinik Değişkenlerle Olan İlişkisi

Pages
76–81
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, due to the usage of NO as a confidential parameter for clinical characteristics, classification and prognosis in schizophrenia, it is needed to determine further studies in future.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In the present study, serum nitric oxid (NO) levels and its relationship with clinical variables in schizophrenia subtypes were evaluated.
📊
Key Findings & Data:Material and Method: The study group was composed of 21 paranoid type, 20 disorganized type, 19 undifferentiated type and 16 residuel type schizophrenic patients who applied to Firat University School of Medicine Department of Psychiatry and 25 healthy control subjects.
💡
Conclusion & Impact:In addition, due to the usage of NO as a confidential parameter for clinical characteristics, classification and prognosis in schizophrenia, it is needed to determine further studies in future.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In the present study, serum nitric oxid (NO) levels and its relationship with clinical variables in schizophrenia subtypes were evaluated. Material and Method: The study group was composed of 21 paranoid type, 20 disorganized type, 19 undifferentiated type and 16 residuel type schizophrenic patients who applied to Firat University School of Medicine Department of Psychiatry and 25 healthy control subjects. The patients were administered sociodemographical and clinical data form and Brief Psyhiatric Rating Scale (BPRS). Blood samples were obtained from the patients and controls between 08.00-11.00 hours. Afterwards, serum NO were determined with Griess reaction. Results: The comparison of schizophrenic patients and healthy controls has shown that serum levels of NO in schizophrenic patients are higher than in healthy ones (p 0.05). Conclusion: Our findings suggest that NO may have an important role for explaining the ethiopathophysiology of schizophrenia. In addition, due to the usage of NO as a confidential parameter for clinical characteristics, classification and prognosis in schizophrenia, it is needed to determine further studies in future.

Özet

Amaç: Bu çalışmada şizofreni alt tiplerinde, serum nitrik oksit (NO) düzeyleri ve klinik değişkenlerle olan ilişkisi araştırılmıştır. Gereç ve Yöntem: Çalışma süresince Fırat Üniversitesi Hastanesi Psikiyatri Kliniği’ne başvuran ve yatarak ya da ayaktan tedavi gören, şizofreni tanısı almış ve çalışma ölçütlerine uyan 21 paranoid tip, 20 dezorganize tip, 19 farklılaşmamış tip ve 16 rezidüel tip şizofren hasta ile 25 sağlıklı kontrol grubu çalışmaya dahil edilmiştir. Hastalara sosyodemografik ve klinik bilgi formu ve Kısa Psikiyatrik Değerlendirme Ölçeği (KPDÖ) uygulanmıştır. Kan örnekleri, çalışma kriterlerine uyan hasta ve kontrol gruplarından sabah 08.00–11.00 saatleri arasında alınarak, Griess Reaksiyonuyla serum NO düzeylerine bakılmıştır. Bulgular: Şizofren hastalarla sağlıklı kontroller karşılaştırıldığında; şizofren hastaların serum NO düzeyleri, kontrol grubuna göre (p 0.05). Sonuç: Bulgularımız şizofreni etyopatogenezini açıklamada NO'nun önemli bir molekül olduğunu düşündürmektedir. Aynı zamanda NO'nun hastalığın klinik seyri, sınıflaması ve prognozu açısından güvenilir bir parametre olarak kullanılabilmesi için daha ileri çalışmalara ihtiyaç vardır.

🔖

Cite This Article

GÜL, Ö., ATMACA, M. (2022). Nitric Oxide Serum Levels in Schizophrenia Subtypes and it’s Relationship with Clinical Variables. Fırat Tıp Dergisi, Cilt: 27 - Sayı: 2, 76–81. https://ajindex.com/articles/513379

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Kültür S, Mete L. Şizofreni. Köroğlu E, Güleç C (Eds). Psikiyatri Temel Kitabı. Ankara: Hekimler Yayın Birliği, 1997: 321-53
  2. Yüksel N. Ruhsal Hastalıklar. Ankara: Çizgi Tıp Yayınevi, 2001: 256-303
  3. Aker T, Erkoç Ş. Şizofrenide belirti ve bulgular, Şizofreni, cilt 1, Erkoç Ş ve Oral T (Ed), İstanbul, Okyanus yayınları 1998: 22-40
  4. Cooper B & Helgason T (Eds). Epidemiology and the Prevention of Mental Disorders (1st ed). Routledge. 1989
  5. Kaplan HI, Saddock BJ. Comprehensive Textbook of Psychiatry. Fifth edition, Baltimore, Williams& Wilkins 1997: 378-396
  6. Koşay S, Bayındır O, Soydan İ & Ülker S. Nitrik oksidin patolojik olaylardaki rolü. Ege Üniversitesi Tıp Fakültesi Ayın Kitabı 1996; 83: 26
  7. Moncada S, Palmer RM & Higgss EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological reviews 1991; 43: 109-42
  8. Meller ST, Gebhart GF. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993; 52: 127-36
  9. Pogun S, Baumann MH, Kuhar MJ. Nitric oxide inhibits [3H] dopamine uptake. Brain Research 1994; 641: 83-91
  10. Karatinos J, Rosse RB, Deutsch SI. The nitric oxide pathway: potential implications for treatment of neuropsychiatric disorders. Clin Neuropharmacol 1995; 18: 482-99
  11. Karson CN, Griffin WS, Mrak RE et al. Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermis. Mol Chem Neuropathol 1996; 27: 3: 275-84
  12. Das I, Khan NS, Puri BK, Sooranna SR, de Belleroche J, Hirsch SR. Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. Biochem. Biophys. Res. Commun 1995; 212: 375-80
  13. Das I, Ramchand CN, Gliddon A, Hirsch SR. Nitric oxide, free radicals and polyamines may have a role in the membrane pathology of schizophrenia. Neuropsychobiology 1998; 37: 65-7
  14. Srivastava N, Barthwal MK, Dalal PK et al. Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients. Psychopharmacology 2001; 158: 2: 140-5
  15. Ramirez J, Garnica R, Boll MC, Montes S, Rios C. Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients. Schizophrenia Research 2004; 68: 357-61
  16. Yanık M, Vural H, Koçyiğit A et al. Is the arginine- nitric oxide pathway involved in the pathogenesis of schizophrenia? Neuropsychobiology 2003; 47: 61-5
  17. Suzuki E, Nakaki T, Nakamura M, Miyaoka H. Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia. J Psych